FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors

FORTIS

250.4
-2.15 (-0.85%)
Updated 01:26 30/07 IST

FORTIS Buy or Sell - FrontPage Forums

2 Users have submitted 2 trade ideas of Rs. 251,350 for FORTIS
Disclaimer
100% Bullish
0% Bearish

FORTIS Buy or Sell - Brokerage Reports

No. of reports in last year
0
No. of analysts
0
Average Consensus Forecast
Consensus Potential
0.00%
See FORTIS Share Price Targets >>

FORTIS Ratings

Long term FORTIS rating by FrontPage users
0/5 (0 Ratings)0
Find answers to all your questions on live FORTIS message board: Is FORTIS buy or sell? Should I buy FORTIS shares? Why are FORTIS shares falling? Should I invest in FORTIS stock?

  1. Home
  2. FORTIS Forum

FORTIS Share Price Discussion

U
Reputation: 0 • Jul 28 4:06 AM
Like
Reply

Type
Buy
Instrument
FORTIS
Entry Price
₹253
Price@Trade
₹253.3
Target Price
₹290
Stop Price
₹150
Valid Till
Aug 27, 2021 3:20 AM
Margin
₹253,000 approx for 1000 Qty
Status
Exited before entry
Like
Reply (1)
swap_vert
Trade
See all replies
Hukam Singh @hukamsingh506
Jul 28 3:40 AM

Update
Exited before entry
Price @ Update
₹254.7
U
Reputation: 0 • Jul 28 3:06 AM
Like
Reply

Type
Buy
Instrument
FORTIS
Entry Price
₹258
Price@Trade
₹258.05
Target Price
₹350
Stop Price
₹250
Valid Till
Aug 27, 2021 3:20 AM
Margin
₹258,000 approx for 1000 Qty
Status
Active
Like
Reply (1)
swap_vert
Trade
See all replies
TrackerBot @trackerbot
Jul 28 3:01 AM

Update
Trade Entered
Entry Price
₹258
U
Reputation: 0 • Jul 27 8:48 AM
Like
Reply

Type
Buy
Instrument
FORTIS
Entry Price
₹256
Price@Trade
₹255.85
Target Price
₹275
Stop Price
₹249
Valid Till
Jul 28, 2021 3:20 AM
Margin
₹25,600 approx for 100 Qty
Status
Active
Like
Reply (1)
swap_vert
Trade
See all replies
TrackerBot @trackerbot
Jul 27 7:22 AM

Update
Trade Entered
Entry Price
₹256
U
Reputation: 0 • Jul 27 3:08 AM
Like
Reply

Type
Buy
Instrument
FORTIS
Entry Price
₹247.05
Price@Trade
₹247.05
Target Price
₹300
Stop Price
₹220
Valid Till
Jul 27, 2022 3:20 AM
Margin
₹2,470.5 approx for 10 Qty
Status
Active
Like
Reply
swap_vert
Trade
S
Reputation: 4,056 • Jul 26 2:51 AM

26-07-2021
BUY FORTIS --> NSE (Positional Short-MID Term)
Only Above @ 248.70
**SL & TGT only for premium members**

Like
Reply (2)
See all replies
Sameer  @tradingfab
Jul 27 3:17 AM

high 251 🔥🔥🔥🔥🚀🚀🤑🤑🤑
Sameer  @tradingfab
Jul 27 9:18 AM

FORTIS - High 257 🔥🔥🔥🚀🚀🚀🤑🤑🤑 3.33% Up 🚀🤑🤑💥 **Premium channel call**

Type
Buy
Instrument
FORTIS
Entry Price
₹240.25
Price@Trade
₹240.25
Target Price
₹260
Stop Price
₹230
Valid Till
Aug 23, 2021 3:20 AM
Margin
₹24,025 approx for 100 Qty
Status
Exited
Exit Price
₹251
Net P&L
+₹1,075 (+4.47%)

Like
Reply (1)
swap_vert
Trade
See all replies
Eldhose @eldhose-HJSznV9QD
Jul 27 5:48 AM

Update
Exited
Exit Price
₹251
Net P&L
+₹1,075 (+4.47%)
N
Reputation: 15,707 • Jul 21 5:21 AM
Delhi Police files fresh FIR against Malvinder and Shivinder for Rs 400 crore 'fraud'
According to the FIR, Malvinder and Shivinder Singh, the former promoters of Fortis, have allegedly duped the company of over ₹crore, siphoning off the money for personal gain and to pay off their loans. “Enquiry has substantiated allegations of the complainant wherein promoters in conspiracy with their associates indulged in criminal breach of trust and criminal misappropriation by diverting the funds of the company,” the FIR says.
The Economic Times
Like
Reply

Type
Buy
Instrument
FORTIS
Entry Price
₹239.8
Price@Trade
₹239.8
Target Price
₹1,000
Stop Price
₹100
Valid Till
Jul 20, 2021 3:20 AM
Margin
₹47,960 approx for 200 Qty
Status
Exited
Exit Price
₹240
Net P&L
+₹40 (+0.08%)

Like
Reply (1)
swap_vert
Trade
See all replies
Sachin Dubey @sachindubey
Jul 20 7:19 AM

Update
Exited
Exit Price
₹240
Net P&L
+₹40 (+0.08%)
N
Reputation: 15,707 • Jul 16 1:46 AM
Private hospitals struggle with drastic fall in Covid immunisation
They need to put in a request on the portal and pay in advance, after which an approval comes from the vaccine manufacturers. No supply date is shared with the hospitals.
The Economic Times
Like
Reply

Type
Buy
Instrument
FORTIS
Entry Price
₹240.35
Price@Trade
₹240.35
Target Price
₹243.75
Stop Price
₹237
Valid Till
Jul 15, 2021 3:20 AM
Margin
₹24,035 approx for 100 Qty
Status
Stoploss Hit
Exit Price
₹237
Net P&L
-₹335 (-1.39%)
Like
Reply (1)
swap_vert
Trade
See all replies
TrackerBot @trackerbot
Jul 15 5:30 AM

Update
Stoploss Hit
Exit Price
₹237

Type
Sell
Instrument
FORTIS
Entry Price
₹242  ₹241
Price@Trade
₹241.45
Target Price
₹238
Stop Price
₹245
Valid Till
Jul 15, 2021 3:20 AM
Margin
₹482,000 approx for 2000 Qty
Status
Target Achieved
Exit Price
₹238
Net P&L
+₹6,000 (+1.24%)
Like
Reply (3)
swap_vert
Trade
See all replies

Update
Entry Price Modified
Price @ Update
₹240.8
Original Entry Price
₹242
New Entry Price
241.0
TrackerBot @trackerbot
Jul 14 8:06 AM

Update
Trade Entered
Entry Price
241.0
TrackerBot @trackerbot
Jul 14 8:49 AM

Update
Target Achieved
Exit Price
₹238
R
Reputation: 0 • Jul 12 5:37 AM

Type
Buy
Instrument
FORTIS
Entry Price
₹237.7
Price@Trade
₹237.7
Target Price
₹250
Stop Price
₹230
Valid Till
Aug 12, 2021 3:20 AM
Margin
₹1,901.6 approx for 8 Qty
Status
Target Achieved
Exit Price
₹250
Net P&L
+₹98.4 (+5.17%)
Like
Reply (1)
swap_vert
Trade
See all replies
TrackerBot @trackerbot
Jul 27 2:59 AM

Update
Target Achieved
Exit Price
₹250

Type
Buy
Instrument
FORTIS
Entry Price
₹239
Price@Trade
₹239.3
Target Price
₹250
Stop Price
₹230
Valid Till
Jul 9, 2021 3:20 AM
Margin
₹23,900 approx for 100 Qty
Status
Validity Over
Exit Price
₹237.1
Net P&L
-₹190 (-0.79%)
Like
Reply (2)
swap_vert
Trade
See all replies
TrackerBot @trackerbot
Jul 9 4:36 AM

Update
Trade Entered
Entry Price
₹239
TrackerBot @trackerbot
Jul 9 8:50 AM

Update
Validity Over
Exit Price
₹237.1
Net P&L
-₹190 (-0.79%)
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 2,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
  • FORTIS - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization10,252.22
    Enterprise Value6,866.35
    Price to Earnings188.88
    Price to Book Value1.23
    Return on Capital EmployedNA
    Return on Equity-0.02
    Face Value10
    Dividend YieldNA
  • FORTIS - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    16-Mar-18ICICIdirect.comBuy200
    1-Mar-18Motilal OswalBuy185
    16-Nov-17Motilal OswalBuy185
    10-Aug-17Axis DirectBuy191
    8-Aug-17Motilal OswalBuy220
    FORTIS Brokerage Price Target
  • FORTIS Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Jul 29251.25255246.7252.55
    Jul 28257.3259.8245.1249.7
    Jul 27247.1257.05246.6254.95
    Jul 26241.9248.15240246.65
    Jul 23237.25243.8237.25241.9
  • FORTIS Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹242.37
    30 Day Moving Average₹240.26
    50 Day Moving Average₹236.21
    100 Day Moving Average₹220.89
    200 Day Moving Average₹185.71
  • FORTIS - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue659645.120.02
    Operating Profit-113-151.77-0.26
    Profit Before Tax-60-114.04-0.47
    Net Income-64-74.7-0.14
  • FORTIS - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds8,3634,2270.98
    Total Liabilities1,7578001.2
    Total Assets10,1205,0271.01
  • FORTIS - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity-7629.13-3.61
    Cash from Investing Activity301-79.88-4.77
    Cash from Financing Activity-28747.35-7.06
    Net Cash Flow-62-3.4117.18
  • FORTIS - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets-0.01-0.01
    Return on Equity-0.02-0.02
    Return on Capital EmployedNANA
  • FORTIS - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.08
    3 Year CAGR Growth in Operating Profit0.26
    3 Year CAGR Growth in EBIDTA-0.55
    3 Year CAGR Growth in Net Income-0.89
    3 Yr CAGR Growth - Diluted EPS-0.68
  • FORTIS - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue0.84
    5 Year CAGR Growth in Operating Profit-95.58
    5 Year CAGR Growth in EBIDTA-0.83
    5 Year CAGR Growth in Net Income-4.71
    3 Yr CAGR Growth - Diluted EPS-3.86
  • FORTIS - Recent News

    keyboard_arrow_down
    NewsBot
    Jul 21 5:21 AM
    Delhi Police files fresh FIR against Malvinder and Shivinder for Rs 400 crore 'fraud'
    The Economic Times
    NewsBot
    Jul 16 1:46 AM
    Private hospitals struggle with drastic fall in Covid immunisation
    The Economic Times
    NewsBot
    Jul 8 1:36 AM
    Rising long Covid cases a new worry for hospitals
    The Economic Times
    NewsBot
    Jun 29 2:11 AM
    Russian made COVID-19 vaccine Sputnik V's commercial launch delayed
    The Economic Times
    NewsBot
    Jun 22 1:21 AM
    How Work From Home culture is changing the face of work
    The Economic Times
    NewsBot
    Jun 22 11:06 AM
    Jhunjhunwala says commodity cycle has just begun; steel rally not over
    The Economic Times
    NewsBot
    Jun 18 1:31 AM
    Fortis to offer Sputnik V vaccine
    The Economic Times
    NewsBot
    Jun 18 1:16 AM
    Hospitals start process to get Johnson & Johnson vaccine from EU quota
    The Economic Times
    NewsBot
    Jun 17 11:11 AM
    Fortis Healthcare says COVID vaccines protected 92% vaccinated healthcare workers
    The Economic Times
    NewsBot
    Jun 16 12:06 PM
    Select midcaps expected to buck Covid 2.0 blues
    The Economic Times
  • FORTIS - Related Communities

    keyboard_arrow_down
    Sun Pharmaceutical Industries Ltd. NS...
    Cipla Ltd. NSE: CIPLA | BSE: 500087 |...
    Aurobindo Pharma Ltd. NSE: AUROPHARMA...
    Biocon Ltd. NSE: BIOCON | BSE: 532523...
    Lupin Ltd. NSE: LUPIN | BSE: 500257 |...
    Dr. Reddy's Laboratories Ltd. NSE: DR...
    Glenmark Pharmaceuticals Ltd. NSE: GL...
    Divi's Laboratories Ltd. NSE: DIVISLA...
    Piramal Enterprises Ltd. NSE: PEL | B...
    Cadila Healthcare Ltd. NSE: CADILAHC ...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.

PrivacyTerms
FrontPage © 2020